A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.

High-throughput optimization of Ir-catalyzed C-H borylation: a tutorial for practical applications.

Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain.

Therapies for mantle cell lymphoma: current challenges and a brighter future.

Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.

Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.

New and emerging therapies for bone metastases in genitourinary cancers.

Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.

Abiraterone in metastatic prostate cancer without previous chemotherapy.

Morphometric analysis of Huntington's disease neurodegeneration in Drosophila.